C-reactive protein is increased in schizophrenia but is not altered by antipsychotics : meta-analysis and implications

The inflammatory hypothesis of schizophrenia (SZ) posits that inflammatory processes and neural-immune interactions are involved in its pathogenesis, and may underpin some of its neurobiological correlates. SZ is the psychiatric disorder causing the most severe burden of illness, not just owing to its psychiatric impairment, but also owing to its significant medical comorbidity. C-reactive protein (CRP) is a commonly used biomarker of systemic inflammation worldwide. There are some conflicting results regarding the behaviour of CRP in SZ. The aims of this study were to verify whether peripheral CRP levels are indeed increased in SZ, whether different classes of antipsychotics divergently modulate CRP levels and whether its levels are correlated with positive and negative symptomatology. With that in mind, we performed a meta-analysis of all cross-sectional studies of serum and plasma CRP levels in SZ compared to healthy subjects. In addition, we evaluated longitudinal studies on CRP levels before and after antipsychotic use. Our meta-analyses of CRP in SZ included a total of 26 cross-sectional or longitudinal studies comprising 85 000 participants. CRP levels were moderately increased in persons with SZ regardless of the use of antipsychotics and did not change between the first episode of psychosis and with progression of SZ (g=0.66, 95% confidence interval (95% CI) 0.43 to 0.88, P<0.001, 24 between-group comparisons, n=82 962). The extent of the increase in peripheral CRP levels paralleled the increase in severity of positive symptoms, but was unrelated to the severity of negative symptoms. CRP levels were also aligned with an increased body mass index. Conversely, higher age correlated with a smaller difference in CRP levels between persons with SZ and controls. Furthermore, CRP levels did not increase after initiation of antipsychotic medication notwithstanding whether these were typical or atypical antipsychotics (g=0.01, 95% CI -0.20 to 0.22, P=0.803, 8 within-group comparisons, n=713). In summary, our study provides further evidence of the inflammatory hypothesis of SZ. Whether there is a causal relationship between higher CRP levels and the development of SZ and aggravation of psychotic symptoms, or whether they are solely a marker of systemic low-grade inflammation in SZ, remains to be clarified.

Molecular targets in arthritis and recent trends in nanotherapy

Due to its severity and increasing epidemiology, arthritis needs no description. There are various forms of arthritis most of which are disabling, very painful, and common. In spite of breakthroughs in the field of drug discovery, there is no cure for arthritis that can eliminate the disease permanently and ease the pain. The present review focuses on some of the most successful drugs in arthritis therapy and their side effects. Potential new targets in arthritis therapy such as interleukin-1β, interleukin-17A, tumor necrosis factor alpha, osteopontin, and several others have been discussed here, which can lead to refinement of current therapeutic modalities. Mechanisms for different forms of arthritis have been discussed along with the molecules that act as potential biomarkers for arthritis. Due to the difficulty in monitoring the disease progression to detect the advanced manifestations of the diseases, drug-induced cytotoxicity, and problems with drug delivery; nanoparticle therapy has gained the attention of the researchers. The unique properties of nanoparticles make them highly attractive for the design of novel therapeutics or diagnostic agents for arthritis. The review also focuses on the recent trends in nanoformulation development used for arthritis therapy. This review is, therefore, important because it describes the relevance and need for more arthritis research, it brings forth a critical discussion of successful drugs in arthritis and analyses the key molecular targets. The review also identifies several knowledge gaps in the published research so far along with the proposal of new ideas and future directions in arthritis therapy.

Efficient and selectable production of reactive species using a nanosecond pulsed discharge in gas bubbles in liquid

A plasma gas bubble-in-liquid method for high production of selectable reactive species using a nanosecond pulse generator has been developed. The gas of choice is fed through a hollow needle in a point-to-plate bubble discharge, enabling improved selection of reactive species. The increased interface reactions, between the gas-plasma and water through bubbles, give higher productivity. H2O2 was the predominant species produced using Ar plasma, while predominantly NO3- and NO2 were generated using air plasma, in good agreement with the observed emission spectra. This method has nearly 100% selectivity for H2O2, with seven times higher production, and 92% selectivity for NO3-, with nearly twice the production, compared with a plasma above the water.

Nonlinear backstepping controller design for sharing active and reactive power in three-phase grid-connected photovoltaic systems

In this paper, a nonlinear backstepping controller is designed for three-phase grid-connected solar photovoltaic (PV) systems to share active and reactive power. A cascaded control structure is considered for the purpose of sharing appropriate amount of power. In this cascaded control structure, the dc-link voltage controller is designed for balancing the power flow within the system and the current controller is designed to shape the grid current into a pure sinusoidal waveform. In order to balance the power flow, it is always essential to maintain a constant voltage across the dc-link capacitor for which an incremental conductance (IC) method is used in this paper. This approach also ensures the operation of solar PV arrays at the maximum power point (MPP) under rapidly changing atmospheric conditions. The proposed current controller is designed to guarantee the current injection into the grid in such a way that the system operates at a power factor other than unity which is essential for sharing active and reactive power. The performance of the proposed backstepping approach is verified on a three-phase grid-connected PV system under different atmospheric conditions. Simulation results show the effectiveness of the proposed control scheme in terms of achieving desired control objectives.

Experimental investigation on bonding properties of reactive liquid rubber epoxy in CFRP retrofitted concretet members

The load bearing capacity of aging reinforced concrete structures, such as bridges, is increasingly extended with the use of Carbon Fibre Reinforced Polymer (CFRP). Premature failure, which is attributed to the rigid behaviour of the bonding agent (epoxy resin) and the high stresses at the interface region, can occur because of the debonding of CFRP sheets from host surfaces. To overcome the debonding issue, the epoxy resin is modified by different reactive liquid polymers to improve its toughness, flexibility, adhesion, and impact resistance. This study reports the usage of two reactive liquid polymers, namely, liquid Carboxyl-Terminated Butadiene-Acrylonitrile (CTBN) and liquid Amine-Terminated Butadiene-Acrylonitrile (ATBN), to improve the mechanical properties of the commercially available MBrace saturant resin when added to a ratio of 100:30 by weight. The neat and modified epoxies were analysed using the Dynamic Mechanical Thermal Analysis (DMTA) to determine and compare the storage modulus and glass transition temperatures of these materials. Moreover, the bonding strength of neat and modified epoxies was evaluated through single-lap shear tests on CFRP sheets bonded to concrete prisms. The results indicate that the modified resins exhibited improved ductility and toughness and became reasonably flexible compared with the neat epoxy resin. The improved properties will help delay the premature debonding failure in CFRP retrofitted concrete members.